Camden National Bank Pfizer Inc Transaction History

Camden National Bank

$552 Million
Q1 2024

A detailed history of Camden National Bank transactions in Pfizer Inc stock. As of the latest transaction made, Camden National Bank holds 12,025 shares of PFE stock, worth $333,092. This represents 0.06% of its overall portfolio holdings.

Number of Shares

12,025

Previous 12,300 2.24%

Holding current value

$333,092

Previous $354,000 5.93%

% of portfolio

0.06%

Previous 0.07%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	SELL	$25.89 - $29.73 $7,119 - $8,175	-275 Reduced 2.24%	12,025 $333,000
Q4 2023 Feb 12, 2024	SELL	$26.13 - $33.94 $100,495 - $130,533	-3,846 Reduced 23.82%	12,300 $354,000
Q3 2023 Nov 03, 2023	SELL	$32.09 - $37.51 $53,269 - $62,266	-1,660 Reduced 9.32%	16,146 $535,000
Q2 2023 Aug 09, 2023	SELL	$36.12 - $41.79 $75,743 - $87,633	-2,097 Reduced 10.54%	17,806 $653,000
Q1 2023 May 08, 2023	BUY	$39.39 - $51.28 $394,136 - $513,107	10,006 Added 101.1%	19,903 $812,000

Q4 2022 Feb 10, 2023	SELL	$41.75 - $54.5 $170,507 - $222,578	-4,084 Reduced 29.21%	9,897 $507,000
Q3 2022 Nov 04, 2022	SELL	$43.76 - $53.42 $5,557 - $6,784	-127 Reduced 0.9%	13,981 $612,000
Q2 2022 Aug 09, 2022	SELL	$46.53 - $55.17 $3,722 - $4,413	-80 Reduced 0.56%	14,108 $740,000
Q1 2022 May 05, 2022	SELL	$45.75 - $56.69 $25,345 - $31,406	-554 Reduced 3.76%	14,188 $735,000
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $10,412 - $15,435	252 Added 1.74%	14,742 $871,000
Q3 2021 Nov 09, 2021	SELL	$39.25 - $50.42 $3,571 - $4,588	-91 Reduced 0.62%	14,490 $623,000
Q2 2021 Aug 09, 2021	SELL	$35.91 - $40.68 $35,658 - $40,395	-993 Reduced 6.38%	14,581 $571,000
Q1 2021 Aug 04, 2021	BUY	$33.49 - $37.77 $55,158 - $62,207	1,647 Added 11.83%	15,574 $565,000
Q4 2020 Feb 01, 2021	SELL	$33.47 - $42.56 $61,450 - $78,140	-1,836 Reduced 11.65%	13,927 $512,000
Q3 2020 Nov 05, 2020	SELL	$31.75 - $37.25 $54,324 - $63,734	-1,711 Reduced 9.79%	15,763 $578,000
Q2 2020 Aug 13, 2020	SELL	$30.12 - $36.54 $27,409 - $33,251	-910 Reduced 4.95%	17,474 $571,000
Q1 2020 May 14, 2020	SELL	$27.03 - $38.62 $119,040 - $170,082	-4,404 Reduced 19.33%	18,384 $600,000
Q4 2019 Feb 11, 2020	BUY	$32.92 - $37.36 $5,365 - $6,089	163 Added 0.72%	22,788 $893,000
Q3 2019 Oct 11, 2019	BUY	$32.49 - $42.13 $116,119 - $150,572	3,574 Added 18.76%	22,625 $813,000
Q2 2019 Aug 08, 2019	BUY	$36.98 - $41.52 $279,790 - $314,140	7,566 Added 65.88%	19,051 $825,000
Q1 2019 May 08, 2019	BUY	$37.5 - $41.2 $337 - $370	9 Added 0.08%	11,485 $488,000
Q4 2018 Feb 04, 2019	BUY	$38.47 - $43.86 $91,520 - $104,342	2,379 Added 26.15%	11,476 $500,000
Q3 2018 Nov 08, 2018	BUY	$34.47 - $41.81 $1,792 - $2,174	52 Added 0.57%	9,097 $401,000
Q2 2018 Aug 10, 2018	BUY	$32.98 - $35.16 $30,836 - $32,874	935 Added 11.53%	9,045 $328,000
Q4 2017 Feb 12, 2018	BUY	$33.26 - $35.29 $32,761 - $34,760	985 Added 13.82%	8,110 $294,000
Q3 2017 Nov 09, 2017	BUY	$31.0 - $34.15 $220,875 - $243,318	7,125	7,125 $255,000

Others Institutions Holding PFE

# of Institutions

3,158

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $155B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Camden National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Camden National Bank with notifications on news.

Account

Camden National Bank Pfizer Inc Transaction History